JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2010, Vol. 48 ›› Issue (6): 26-.

• Articles • Previous Articles     Next Articles

Inhibiting effects of combinative treatment of retinoblastoma 94 with radiotherapy in a mouse xenograft model

ZHANG Ping1, LIU Fang2, LUAN Li1, MA Daoxin1, WANG Jianbo1, TAN Bingxu1, CHENG Yufeng1   

  1. 1. Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan 250012, China;
    2. Department of Radiation, Shandong Medical College, Jinan 250002, China
  • Received:2009-03-03 Online:2010-06-16 Published:2010-06-16

Abstract:

Objective  To investigate the effects and mechanisms of radiosensitising enhancement of Rb94 gene in nude mice xenograft model. Methods  5×106 cells suspension was subcutaneously injected into flanks of 40 nude mice. Then the inoculated mice were devided into 8 groups after tumors reached 180mm3: no treatment group and XRT alone goup treated with PBS, lipofectamine treatment group and lipofectamine with XRT group treated with lipofectamine, pIRES treatment group and pIRES with XRT group treated with pIRES empty vector, pIRESRb94 treatment group and pIRESRb94 with XRT group treated with pIRES-Rb94.  X-ray was given to XRT alone group, lipofectamine with XRT group, pIRES with XRT group and pIRES-Rb94 with XRT group. The tumor inhibiting rate was observed and the expression of Rb94 gene was detected by Real time RT-PCR and Western blot. The number of apoptosis cells was measured by Hoechst staining. Expressions of hTERT and Bcl-2mRNA were detected by Real time RT-PCR. Cell cycle blockage was measured by Immunohistology(IF). Results  The inhibited ratio of pIRES-Rb94 with XRT group tumor was 95.84%, and statistically significant differences in the inhibition ratios were found between the pIRESRb94 with XRT group and the other groups (pIRES-Rb94 treatment group and XRT alone group). Conclusion  It is suggested that Rb94 has inhibitory effects for inoculated tumor in nude mice. The tumor inhibition rate of pIRESRb94 with XRT group seems to be higher than those in other groups. The mechanisms of  radiosensitising enhancement of Rb94 gene may include cell apoptosis, G2/M phase blocking and down-regulation of hTERT and Bcl-2 mRNA expressions.

Key words: Genes, retinoblastoma; A549 cells; Radiosensitivity; Mouse, nude

CLC Number: 

  • R734.2
[1] XU Xiao-ya, BI Yu-li, JIANG Man, XU Ji-ying, ZHANG Peng-fei, HAN Ming-yong. Vascular endothelial growth factor (VEGF) promotes lung carcinoma metastasis via VEGFR1 in mouse model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 25-29.
[2] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 108-110.
[3] TIAN Tian-tian1, LI Ji-sheng1, WANG Ya-wei1, MA Dao-xin2, WANG Xiu-wen1. Genistein exerts antitumor effects in small cell lung cancer H446 cells via suppressing the activity of FoxM1 pathway [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(06): 44-48.
[4] LIU Bing1, YU Zhuang1, HOU Xian-peng1, YAO Ru-yong2. Different expressions of EGFR and HER-3 genes in human lung adenocarcinoma cells and pemetrexed-resistant cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 20-23.
[5] ALIMUJIANG·Stiwaerdi, ZHANG Tao, PATIGULI·Aerxiding, LIU Li. Clinical analysis of recombinant human endostatin combined with gemcitabine and  cisplatin therapy in advanced non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 95-98.
[6] DONG Xue-li, MU Xiao-yan, LIU Qing-liang, SUN Jie. Effects of erlotinib combined with celecoxib on growth and angiogenesis of human lung cancer xenograft model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 49-52.
[7] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(10): 130-131.
[8] LIU Qing-liang1, MU Xiao-yan1, WANG-Jing2, CHI Xiang-yu2, ZHANG Min3, MA Wei-xia3. Inhibitory effects of RNA interference and Erlotinib by blocking epidermal
growth factor receptor pathway on the proliferation of A549 cells
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 11-.
[9] FAN Heng-jian, ZHANG Yu-ke, XIAO Wei, ZHANG Yi, LI Hai-jun, WANG De-xiang. Changes of Treg and Th17 cells in the peripheral bloods of patients with
lung adenocarcinoma and their prognostic significance
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 73-78.
[10] WANG Ji-xia, LI Gui-xin, HUANG Yan, WANG Li-juan. Expressions and clinical significances of E1AF,MMP-7 and uPA in nonsmall cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 109-.
[11] XU Tong-zhen, SUN Xue-fei, REN Dong-mei, YANG Guo-tao. Antiproliferation activity of luteolin and its role in combined chemotherapy on lung cancer A549 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 50-54.
[12] LIU Hai-rong1, YU Jin-ming2, LI Yan1, LIANG Jing1, LIU Xiao-lin1. Study of the relationship between ER, PR, C-erB-2 and
bone metastasis of  lung adenocacinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(4): 91-.
[13] MA Yu-hua1,2, ZHENG Yan3, JIA Yan-fei3, WANG Yun-shan3. GFR and DEC1 protein co-expression promotes lymph node
metastasis in lung adenocarcinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 24-28.
[14] SUN Xue-fei, PEI Yan-tao,YIN Qiu-wei, YANG Guo-tao, WANG De-jiang. Inhibitory effect of Radix Actinidiae extractive on transplantation
tumor of the lung cancer cell line A549 in nude mice
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 38-42.
[15] LI Peng, LIU Qi, HAN Ming-yong. PET/CT,CEA and CYFRA21-1 predicting the therapeutic effect of targeted drug on non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(1): 129-132.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!